EVAX
Evaxion AS
NASDAQ · Healthcare · Biotechnology · DK
$3.33
+17.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 108.67x
- P/S forward
- 71.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.15x
- Price / sales
- 4.01x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $23.1M
- EV / sales
- 3.09x
- EV / EBITDA
- -2.33x
- EV / EBIT
- -2.66x
- Market cap
- $30.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026